Literature DB >> 19273296

Modulation of opioid receptor function by protein-protein interactions.

Konstantinos Alfaras-Melainis1, Ivone Gomes, Raphael Rozenfeld, Venetia Zachariou, Lakshmi Devi.   

Abstract

Opioid receptors, MORP, DORP and KORP, belong to the family A of G protein coupled receptors (GPCR), and have been found to modulate a large number of physiological functions, including mood, stress, appetite, nociception and immune responses. Exogenously applied opioid alkaloids produce analgesia, hedonia and addiction. Addiction is linked to alterations in function and responsiveness of all three opioid receptors in the brain. Over the last few years, a large number of studies identified protein-protein interactions that play an essential role in opioid receptor function and responsiveness. Here, we summarize interactions shown to affect receptor biogenesis and trafficking, as well as those affecting signal transduction events following receptor activation. This article also examines protein interactions modulating the rate of receptor endocytosis and degradation, events that play a major role in opiate analgesia. Like several other GPCRs, opioid receptors may form homo or heterodimers. The last part of this review summarizes recent knowledge on proteins known to affect opioid receptor dimerization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273296      PMCID: PMC2859702          DOI: 10.2741/3474

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  127 in total

1.  Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors.

Authors:  K Chaturvedi; P Bandari; N Chinen; R D Howells
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

Review 2.  G-protein-coupled receptor dimerization: modulation of receptor function.

Authors:  C D Rios; B A Jordan; I Gomes; L A Devi
Journal:  Pharmacol Ther       Date:  2001 Nov-Dec       Impact factor: 12.310

Review 3.  G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.

Authors:  Nanda Tilakaratne; Patrick M Sexton
Journal:  Clin Exp Pharmacol Physiol       Date:  2005-11       Impact factor: 2.557

4.  Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3.

Authors:  Rüdiger Schulz; Andrea Wehmeyer; Karin Schulz
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

5.  Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.

Authors:  Jian-Guo Li; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

6.  Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell.

Authors:  D Wang; C K Surratt; W Sadée
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

7.  Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.

Authors:  Y Pak; B F O'Dowd; J B Wang; S R George
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.

Authors:  J G Li; L Y Luo; J G Krupnick; J L Benovic; L Y Liu-Chen
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

9.  EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins.

Authors:  M R Koelle; H R Horvitz
Journal:  Cell       Date:  1996-01-12       Impact factor: 41.582

Review 10.  An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function.

Authors:  Raphael Rozenfeld; Noura S Abul-Husn; Ivone Gomez; Lakshmi A Devi
Journal:  ScientificWorldJournal       Date:  2007-11-02
View more
  11 in total

1.  Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model.

Authors:  Saima Rizwan; Ayesha Idrees; Muhammad Ashraf; Touqeer Ahmed
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

Review 2.  Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.

Authors:  Wendy M Walwyn; Karen A Miotto; Christopher J Evans
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

3.  Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons.

Authors:  Reagan L Pennock; Shane T Hentges
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

Review 4.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 5.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

Review 6.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

7.  Receptor heteromerization and drug discovery.

Authors:  Raphael Rozenfeld; Lakshmi A Devi
Journal:  Trends Pharmacol Sci       Date:  2010-01-07       Impact factor: 14.819

8.  Low expression of D2R and Wntless correlates with high motivation for heroin.

Authors:  Diana M Tacelosky; Danielle N Alexander; Megan Morse; Andras Hajnal; Arthur Berg; Robert Levenson; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2015-10-26       Impact factor: 1.912

9.  Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.

Authors:  Cynthia Wei-Sheng Lee; Jia-Ying Yan; Yao-Chang Chiang; Tsai-Wei Hung; Hung-Li Wang; Lih-Chu Chiou; Ing-Kang Ho
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

10.  Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors.

Authors:  Pei-Chen Wang; Ing-Kang Ho; Cynthia Wei-Sheng Lee
Journal:  J Cell Mol Med       Date:  2015-07-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.